TRIDERM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triderm, and when can generic versions of Triderm launch?
Triderm is a drug marketed by Crown Labs and is included in one NDA.
The generic ingredient in TRIDERM is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triderm
A generic version of TRIDERM was approved as triamcinolone acetonide by TARO on October 1st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIDERM?
- What are the global sales for TRIDERM?
- What is Average Wholesale Price for TRIDERM?
Summary for TRIDERM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 13 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 4,284 |
DailyMed Link: | TRIDERM at DailyMed |
Pharmacology for TRIDERM
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for TRIDERM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Crown Labs | TRIDERM | triamcinolone acetonide | CREAM;TOPICAL | 088042-002 | Mar 25, 2015 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Crown Labs | TRIDERM | triamcinolone acetonide | CREAM;TOPICAL | 088042-001 | Mar 19, 1984 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Crown Labs | TRIDERM | triamcinolone acetonide | CREAM;TOPICAL | 088042-003 | Mar 25, 2015 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |